Vertex Pharmaceuticals, Inc. (VRTX) Tops Q4 EPS by 16c
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Price: $544.52 --0%
Revenue Growth %: +10.7%
Financial Fact:
Royalty revenues: 3.84M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +10.7%
Financial Fact:
Royalty revenues: 3.84M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX) reported Q4 EPS of $0.86, $0.16 better than the analyst estimate of $0.70. Revenue for the quarter came in at $563.3 million versus the consensus estimate of $518.36 million.
For earnings history and earnings-related data on Vertex Pharmaceuticals, Inc. (VRTX) click here.
For earnings history and earnings-related data on Vertex Pharmaceuticals, Inc. (VRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Adjust Monthly US Director's Cut List
- Citi opens downside watch on Kroger ahead of earnings
- Science Applications (SAIC) PT Raised to $154 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
